John P Campbell

Researcher in exercise immunology and exercise oncology.

John joined the Department for Health at Bath in 2016 as a 50th Anniversary Prize Fellow to develop a research program in exercise immuno-oncology. John is collaborating with Bath Royal United Hospital, and national and international collaborators, to investigate whether immunological changes that arise in response to exercise can be harnessed to prevent and treat cancer. In particular, a main focus of John's research is investigating whether exercise can be used as an adjuvant for cancer immunotherapy.

Prior to undertaking his role as a Prize Fellow, John completed his PhD in 2010 at the School of Sport, Exercise and Rehabilitation Sciences at the University of Birmingham UK. During his PhD, John investigated the effects of exercise on immunological competency, which involved conducting randomised-controlled trials to determine whether exercise improves vaccination responses in humans. Following his PhD, John undertook 6 years of post-doctoral training in blood cancers at the Institute of Immunology and Immunotherapy at the University of Birmingham Medical School. During this time, John was involved in the development of the world’s first near-patient test for measuring free light chains (Seralite, Abingdon Health Ltd) - biomarkers for diagnosing and monitoring monoclonal gammopathies including multiple myeloma. John has received principle / co-investigator funding from CRUK, MRC, NIHR, NASA, the Physiological Society and other funding streams.